AU409
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AU409, covering 2026-02-02 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease [Phase 1]